Search - tctmd.com

Displaying 301 - 320 of 369

Sort: Relevancy | Date

News Conference News TCT 2017

One in Six Patients With LBBB Post-TAVR Develop Atrioventricular Block

Michael O'Riordan

October 31, 2017

Presentation TCT 2017

TCT 55: Intentional Laceration of the Anterior Mitral Leaflet to Prevent Left Ventricular Outflow Tract Obstruction (LAMPOON) During TMVR: First-in-Human Findings

Presenter: Karl-Heinz Kuck, Nicolo Piazza, Jaffar M Khan

October 31, 2017

Presentation TCT 2017

Transcatheter Left Ventricular Reconstruction for Treatment of Post-Myocardial Infarction Ischemic Cardiomyopathy

Presenter: Vasilis Babaliaros, Shmuel Banai, Andrew Wechsler

October 30, 2017

News Daily News

High Blood Pressure May Raise Mitral Regurgitation Risk

Todd Neale

October 17, 2017

News Conference News PCR London Valves 2017

Pacemakers and Paravalvular Leak With Lotus: Updates From REPRISE III

Shelley Wood

September 27, 2017

Manuscript

Moving Beyond Linear Formulas for Left Ventricular Mass in Aortic Valve Replacement

September 21, 2017

News Daily News

Permanent Pacemakers Post-TAVR Don’t Increase Adverse Event Risk: Meta-analysis

Ashley Lyles

August 08, 2017

News Features

A Heart to Hold: 3-D Printers Add New Dimension to the Treatment of Structural Cardiac Disease

Yael L. Maxwell

August 02, 2017

News Daily News

Newly Proposed Classification of AS Focuses on Baseline Cardiac Damage as Outcome Predictor

L.A. McKeown

July 26, 2017

News Daily News

Ultrasound May Prove Useful in Softening Calcified Bioprosthetic Valves

Caitlin E. Cox

June 21, 2017

News Conference News TVT 2017

Reacting to REPRISE III: Enthusiasm, Explanations, and Caveats for the Lotus Pivotal TAVR Trial

Shelley Wood

June 16, 2017

News Industry News

4C Medical's Novel Mitral Regurgitation Therapy Highlighted at TVT Innovation Forum

June 16, 2017

News Conference News TVT 2017

Embolic Protection During TAVR Reduces Stroke Risk, Single-Center Study Shows

Michael O'Riordan

June 15, 2017

News Daily News

Lotus Matches Sapien in Single-Center Study, but Pacemaker Use Poses Questions

Michael O'Riordan

June 06, 2017

Manuscript

Percutaneous Ventricular Restoration Using the Parachute Device: The Parachute III PressureVolume Loop Sub-study

May 24, 2017

News Conference News EuroPCR 2017

Bicuspid AS Patients with Calcification Fare Worse After TAVR, But Device Type Matters

Michael O'Riordan

May 17, 2017

News Conference News EuroPCR 2017

If They Survive First Month, Mitral Annular Calcification Patients Treated With Transcatheter Valves Do Well at 1 Year

Shelley Wood

May 17, 2017

REPRISE III: Lotus Valve Matches CoreValve in First Head-to-Head TAVR Trial

News Conference News EuroPCR 2017

REPRISE III: Lotus Valve Matches CoreValve in First, Large Head-to-Head TAVR Trial

Shelley Wood

May 16, 2017

News Daily News

Novel Percutaneous Technique May Allow for TMVR in Patients at High Risk for LVOT Obstruction

Yael L. Maxwell

April 18, 2017

News Daily News

Permanent Pacemakers After TAVR: Model Helps Predict Individual Patient Risk With Sapien 3

L.A. McKeown

April 12, 2017

Advertisement

One in Six Patients With LBBB Post-TAVR Develop Atrioventricular Block

TCT 55: Intentional Laceration of the Anterior Mitral Leaflet to Prevent Left Ventricular Outflow Tract Obstruction (LAMPOON) During TMVR: First-in-Human Findings

Transcatheter Left Ventricular Reconstruction for Treatment of Post-Myocardial Infarction Ischemic Cardiomyopathy

High Blood Pressure May Raise Mitral Regurgitation Risk

Pacemakers and Paravalvular Leak With Lotus: Updates From REPRISE III

Moving Beyond Linear Formulas for Left Ventricular Mass in Aortic Valve Replacement

Permanent Pacemakers Post-TAVR Don’t Increase Adverse Event Risk: Meta-analysis

A Heart to Hold: 3-D Printers Add New Dimension to the Treatment of Structural Cardiac Disease

Newly Proposed Classification of AS Focuses on Baseline Cardiac Damage as Outcome Predictor

Ultrasound May Prove Useful in Softening Calcified Bioprosthetic Valves

Reacting to REPRISE III: Enthusiasm, Explanations, and Caveats for the Lotus Pivotal TAVR Trial

4C Medical's Novel Mitral Regurgitation Therapy Highlighted at TVT Innovation Forum

Embolic Protection During TAVR Reduces Stroke Risk, Single-Center Study Shows

Lotus Matches Sapien in Single-Center Study, but Pacemaker Use Poses Questions

Percutaneous Ventricular Restoration Using the Parachute Device: The Parachute III PressureVolume Loop Sub-study

Bicuspid AS Patients with Calcification Fare Worse After TAVR, But Device Type Matters

If They Survive First Month, Mitral Annular Calcification Patients Treated With Transcatheter Valves Do Well at 1 Year

REPRISE III: Lotus Valve Matches CoreValve in First, Large Head-to-Head TAVR Trial

Novel Percutaneous Technique May Allow for TMVR in Patients at High Risk for LVOT Obstruction

Permanent Pacemakers After TAVR: Model Helps Predict Individual Patient Risk With Sapien 3

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content